Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7269162 capsule formulation and food-effect study in healthy participants
NL-OMON60164Phase 1Completed
- Sponsor
- Roche
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of nivegacetor, sponsored by Roche. Started Sep 2025; status: completed.
02
Drugs
nivegacetor
Beyond the preview
Go deeper on NL-OMON60164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60164.